Prostatype Genomics CFO Michael af Winklerfelt is leaving the company after three years. Michael will resign from his position as of December 4. The company has started the process of finding a replacement for the function as CFO.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0398 SEK | +2.58% | -2.45% | -58.11% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-58.11% | 3.52M | |
-16.55% | 8.43B | |
+40.93% | 3.62B | |
-35.59% | 2.61B | |
-8.06% | 2.48B | |
-8.00% | 2.34B | |
-5.93% | 1.94B | |
-18.96% | 1.56B | |
-38.35% | 1.26B | |
+6.91% | 1.1B |
- Stock Market
- Equities
- PROGEN Stock
- News Prostatype Genomics AB
- Prostatype Genomics CFO Michael af Winklerfelt Leaving the Company